CXCL12 and triple-A syndrome: Additionally, we demonstrate that miR206‐3p deficiency plays a pivotal role in hindering AAA progression, potentially through CXCL12/CXCR4 axis inhibition, underscoring the therapeutic promise of miR206‐3p sponge in AAA treatment.